We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Kirk & Kirk produces a distinctive range of glasses and sunglasses, handmade in France from a particular grade of acrylic, providing a variety of colours. The company aims at earning a unique position in capitalising on a rapidly-developing market with opportunities to grow in wholesale, fashion and online sales. Till date, the company has developed its core markets in the UK, Europe, USA, and Australia. Many celebrities such as Naga Munchetty, Prue Leith, Morcheeba, Morrissey, and Sharon Stone are clients of this fashion brand. The company intent on using the investment for new retail collection, enhancements to the IT infrastructure and the recruitment of key personnel.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Electric Assisted Vehicles Limited or EAV is a new generation vehicle design and manufacturing company providing a world-class solution. In August, the company has been revealed at the UK EV summit in Oxford. DPD is the technical partner of EAV and it has issued Letter of Intent for 50 more EAVans. With the proceeds, the company will expand into the international market, develop the product and will set its business lease plans.

Pitch Rated

79%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £215,130
Stasher is a company that operates an online platform facilitating luggage storage by connecting travelers with local hotels and shops. Available via their website and app, Stasher offers secure and affordable luggage storage options, benefiting both travelers and local businesses, with a mission to enhance travel experiences across a global network of over 600 cities and 75 countries.
days to go: Expired investment: £568,864
Molecular Warehouse are trying to create a world where most diseases are prevented by giving people the chance to monitor and manage their helath where ever and whenever. Molecular Warehouse have developed a platform that allows anyone to test themselves at any time.
days to go: Expired investment: £737,480
Quin is a mobile medical app that combines daily life experience with data from diabetes devices and phones and helps people decide how much insulin to take and when. They are on a mission to help people with insulin-treated diabetes make the best possible decisions through their app. The company have received a UK research and innovation grant. Apple has granted them insider access to their engineers and executives who are helping to get Quin to market, their app has a class I CE Mark, with two patents pending. With the investment, they will hire a product designer to enhance the user experience, achieve certification and compliance with new European Medical Device Regulations, develope B2B2C distribution partnerships and launch the Quin app in the UK and Europe in late 2020.

Pitch Rated

48%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £691,497
Aardvark is a company that manufactures dry kibbles for dogs and cats using insects as the source of protein. It has partnered with VC backed insect farm NextProtein. The company claims that its products meet the nutritional needs of pets while creating a smaller environmental footprint than pet food that uses animal meat. It also asserts that insect protein is endorsed by the British Veterinary Association. The company has developed its kibbles to be grain-free, consist of seaweed and other natural ingredients with no fillers. The UK pet food market is poised to grow to £2.9 billion in 2020, and the company aims to be a sustainable manufacturer in this segment.  The company requires investment to assist in manufacturing its first batch of pet food, help market its products to pet owners across the UK, and expand into Europe by 2021 and the U.S by 2024.
days to go: Expired investment: £300,290
A clothing brand that makes stylish, casual-wear garments in Great Britain targeted at men aged over 35. Blackshore consists of an experienced team that have created their first clothing collection, which is now ready for production after passing a sample test. The theme of this first range is for men who enjoy relaxing at coastal locations. One of the company's unique selling point is that repairs to garments are guaranteed for life. A website has already been built to showcase the brand's products, as well as being a sales channel.
days to go: Expired investment: £13,910
Propnology is a crowdfunding platform specifically designed for property. Founded in 2014, their aim is to encourage a more diverse group of individuals to invest. Propnology allows users to invest in property from as little as £500. 
days to go: Expired investment: £57,209
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £148,736
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph